» Articles » PMID: 36350160

The Burden of Disease in Germany at the National and Regional Level

Abstract

Background: .Summary measures such as disability-adjusted life years (DALY) are becoming increasingly important for the standardized assessment of the burden of disease due to death and disability. The BURDEN 2020 pilot project was designed as an independent burden-of-disease study for Germany, which was based on nationwide data, but which also yielded regional estimates.

Methods: DALY is defined as the sum of years of life lost due to death (YLL) and years lived with disability (YLD). YLL is the difference between the age at death due to disease and the remaining life expectancy at this age, while YLD quantifies the number of years individuals have spent with health impairments. Data are derived mainly from causes of death statistics, population health surveys, and claims data from health insurers.

Results: In 2017, there were approximately 12 million DALY in Germany, or 14 584 DALY per 100 000 inhabitants. Conditions which caused the greatest number of DALY were coronary heart disease (2321 DALY), low back pain (1735 DALY), and lung cancer (1197 DALY). Headache and dementia accounted for a greater disease burden in women than in men, while lung cancer and alcohol use disorders accounted for a greater disease burden in men than in women. Pain disorders and alcohol use disorders were the leading causes of DALY among young adults of both sexes. The disease burden rose with age for some diseases, including cardiovascular diseases, dementia, and diabetes mellitus. For some diseases and conditions, the disease burden varied by geographical region.

Conclusion: The results indicate a need for age- and sex-specific prevention and for differing interventions according to geographic region. Burden of disease studies yield comprehensive population health surveillance data and are a useful aid to decision-making in health policy.

Citing Articles

Depression and health literacy among adolescents and adults in Germany: findings from two representative samples.

Konig L, Schroder R, Hamer T, Suhr R Front Psychol. 2024; 15:1494333.

PMID: 39726619 PMC: 11669750. DOI: 10.3389/fpsyg.2024.1494333.


Cost-effectiveness analysis of mHealth applications for depression in Germany using a Markov cohort simulation.

Freitag B, Uncovska M, Meister S, Prinz C, Fehring L NPJ Digit Med. 2024; 7(1):321.

PMID: 39551808 PMC: 11570631. DOI: 10.1038/s41746-024-01324-0.


Expert recommendations for Germany's integration of psychedelic-assisted therapy.

Perez Rosal S, La Torre J, Birnkammer S, Chernoloz O, Williams M, Faber S BMC Med Educ. 2024; 24(1):1202.

PMID: 39443907 PMC: 11515625. DOI: 10.1186/s12909-024-06141-3.


[Cardiovascular prevention in Saxony-Anhalt : Necessity and new perspectives].

Muller P, Herzog M, Duderstadt Y, Kunz M, Lechner K, Meyer F Inn Med (Heidelb). 2024; 65(11):1137-1146.

PMID: 39387861 PMC: 11543705. DOI: 10.1007/s00108-024-01789-x.


Standardised reporting of burden of disease studies: the STROBOD statement.

Devleesschauwer B, Charalampous P, Gorasso V, Assuncao R, Hilderink H, Idavain J Popul Health Metr. 2024; 22(1):28.

PMID: 39375690 PMC: 11459887. DOI: 10.1186/s12963-024-00347-9.


References
1.
. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392(10159):1736-1788. PMC: 6227606. DOI: 10.1016/S0140-6736(18)32203-7. View

2.
van der Maas P . How summary measures of population health are affecting health agendas. Bull World Health Organ. 2003; 81(5):314. PMC: 2572457. View

3.
Huber J, Lampert T, Mielck A . [Inequalities in health risks, morbidity and health care of children by health insurance of their parents (statutory vs. private health insurance): results of the German KiGGS study]. Gesundheitswesen. 2012; 74(10):627-38. DOI: 10.1055/s-0031-1301268. View

4.
Zhang Y, Lazzarini P, McPhail S, van Netten J, Armstrong D, Pacella R . Global Disability Burdens of Diabetes-Related Lower-Extremity Complications in 1990 and 2016. Diabetes Care. 2020; 43(5):964-974. DOI: 10.2337/dc19-1614. View

5.
Atzendorf J, Rauschert C, Seitz N, Lochbuhler K, Kraus L . The Use of Alcohol, Tobacco, Illegal Drugs and Medicines: An Estimate of Consumption and Substance-Related Disorders in Germany. Dtsch Arztebl Int. 2019; 116(35-36):577-584. PMC: 6804269. DOI: 10.3238/arztebl.2019.0577. View